Quantification of the N-glycosylated secretome by super-SILAC during breast cancer progression and in human blood Samples

Molecular and Cellular Proteomics

Volumn 12, Issue 1, 2013, Pages 158-171

  Boersema, Paul J ^a   Geiger, Tamar ^a,c   Wiśniewski, Jacek R ^a   Mann, Matthias ^a,b  

^a MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^b University of Copenhagen   (Denmark)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MEMBRANE PROTEIN; GLYCOPEPTIDE; GLYCOSYLATED PROTEIN; GLYCOSYLATED SECRETOME; TUMOR MARKER; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ARTICLE; BLOOD SAMPLING; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL CULTURE; CANCER GROWTH; CANCER STAGING; CONTROLLED STUDY; CULTURE MEDIUM; FEMALE; FILTER AIDED SAMPLE PREPARATION; HUMAN; HUMAN CELL; ISOTOPE LABELING; MEASUREMENT ACCURACY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN GLYCOSYLATION; PROTEIN SECRETION; QUANTITATIVE ASSAY; STABLE ISOTOPE LABELING BY AMINO ACIDS IN CELL CULTURE; SUPERNATANT;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MEMBRANE; CULTURE MEDIA, CONDITIONED; DISEASE PROGRESSION; FEMALE; GLYCOPEPTIDES; GLYCOPROTEINS; GLYCOSYLATION; HUMANS; ISOTOPE LABELING; NEOPLASM PROTEINS; PROTEOMICS; TANDEM MASS SPECTROMETRY; TUMOR MARKERS, BIOLOGICAL;

EID: 84871860708     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M112.023614     Document Type: Article

References (71)

1. Hanash, S. M., Baik, C. S., and Kallioniemi, O. (2011) Emerging molecular biomarkers[mdash]blood-based strategies to detect and monitor cancer. Nat. Rev. Clin. Oncol. 8, 142-150
2. Nagaraj, N., Wisniewski, J. R., Geiger, T., Cox, J., Kircher, M., Kelso, J., Paabo, S., and Mann, M. (2011) Deep proteome and transcriptome mapping of a human cancer cell line. Mol. Syst. Biol. 7
3. Beck, M., Schmidt, A., Malmstroem, J., Claassen, M., Ori, A., Szymborska, A., Herzog, F., Rinner, O., Ellenberg, J., and Aebersold, R. (2011) The quantitative proteome of a human cell line. Mol. Syst. Biol. 7
4. Geiger, T., Madden, S. F., Gallagher, W. M., Cox, J., and Mann, M. (2012) Proteomic portrait of human breast cancer progression identifies novel prognostic markers. Cancer Res. 72, 2428-2439
5. Clark, H. F., Gurney, A. L., Abaya, E., Baker, K., Baldwin, D., Brush, J., Chen, J., Chow, B., Chui, C., Crowley, C., Currell, B., Deuel, B., Dowd, P., Eaton, D., Foster, J., Grimaldi, C., Gu, Q. M., Hass, P. E., Heldens, S., Huang, A., Kim, H. S., Klimowski, L., Jin, Y. S., Johnson, S., Lee, J., Lewis, L., Liao, D. Z., Mark, M., Robbie, E., Sanchez, C., Schoenfeld, J., Seshagiri, S., Simmons, L., Singh, J., Smith, V., Stinson, J., Vagts, A., Vandlen, R., Watanabe, C., Wieand, D., Woods, K., Xie, M. H., Yansura, D., Yi, S., Yu, G. Y., Yuan, J., Zhang, M., Zhang, Z. M., Goddard, A., Wood, W. I., and Godowski, P. (2003) The Secreted Protein Discovery Initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: A bioinformatics assessment. Genome Res. 13, 2265-2270 (Pubitemid 37265992)
6. Anderson, N. L., and Anderson, N. G. (2002) The human plasma proteome. Mol. Cell. Proteomics 1, 845-867
7. Anderson, N. L., Polanski, M., Pieper, R., Gatlin, T., Tirumalai, R. S., Conrads, T. P., Veenstra, T. D., Adkins, J. N., Pounds, J. G., Fagan, R., and Lobley, A. (2004) The human plasma proteome. Mol. Cell. Proteomics 3, 311-326 (Pubitemid 38702086)
8. Farrah, T., Deutsch, E. W., Omenn, G. S., Campbell, D. S., Sun, Z., Bletz, J. A., Mallick, P., Katz, J. E., Malmström, J., Ossola, R., Watts, J. D., Lin, B., Zhang, H., Moritz, R. L., and Aebersold, R. (2011) A high-confidence human plasma proteome reference set with estimated concentrations in PeptideAtlas. Mol. Cell. Proteomics 10
9. Berven, F. S., Ahmad, R., Clauser, K. R., and Carr, S. A. (2010) Optimizing performance of glycopeptide capture for plasma proteomics. J. Proteome Res. 9, 1706-1715
10. Zhang, Q., Faca, V., and Hanash, S. (2011) Mining the plasma proteome for disease applications across seven logs of protein abundance. J. Proteome Res. 10, 46-50
11. Wu, C. C., Hsu, C. W., Chen, C. D., Yu, C. J., Chang, K. P., Tai, D. I., Liu, H. P., Su, W. H., Chang, Y. S., and Yu, J. S. (2010) Candidate serological biomarkers for cancer identified from the secretomes of 23 cancer cell lines and the human protein atlas. Mol. Cell. Proteomics 9, 1100-1117
12. Dowling, P., and Clynes, M. (2011) Conditioned media from cell lines: A complementary model to clinical specimens for the discovery of diseasespecific biomarkers. Proteomics 11, 794-804
13. Karagiannis, G. S., Pavlou, M. P., and Diamandis, E. P. (2010) Cancer secretomics reveal pathophysiological pathways in cancer molecular oncology. Mol. Oncol. 4, 496-510
14. Makridakis, M., and Vlahou, A. (2010) Secretome proteomics for discovery of cancer biomarkers. J. Proteomics 73, 2291-2305
15. Pavlou, M. P., and Diamandis, E. P. (2010) The cancer cell secretome: A good source for discovering biomarkers? J. Proteomics 73, 1896-1906
16. Radisky, D. C. (2005) Epithelial-mesenchymal transition. J. Cell Sci. 118, 4325-4326
17. Zent, R., and Pozzi, A. (2009) Cell-extracellular matrix interactions in cancer, Springer.
18. Varki, A., Cummings, R. D., Esko, J. D., Freeze, H. H., Stanley, P., Bertozzi, C. R., Hart, G. W., and Etzler, M. E. (2008) Essentials of glycobiology, 2nd edition.
19. Lisowska, E. (2002) The role of glycosylation in protein antigenic properties. Cell. Mol. Life Sci. 59, 445-455
20. Lau, K. S., and Dennis, J. W. (2008) N-Glycans in cancer progression. Glycobiology 18, 750-760
21. Ohtsubo, K., and Marth, J. D. (2006) Glycosylation in cellular mechanisms of health and disease. Cell 126, 855-867 (Pubitemid 44310784)
22. Drake, P. M., Cho, W., Li, B. S., Prakobphol, A., Johansen, E., Anderson, N. L., Regnier, F. E., Gibson, B. W., and Fisher, S. J. (2010) Sweetening the pot: Adding glycosylation to the biomarker discovery equation. Clin. Chem. 56, 223-236
23. Whitmore, T. E., Peterson, A., Holzman, T., Eastham, A., Amon, L., McIntosh, M., Ozinsky, A., Nelson, P. S., and Martin, D. B. (2012) Integrative analysis of N-linked human glycoproteomic data sets reveals PTPRF ectodomain as a novel plasma biomarker candidate for prostate cancer. J. Proteome Res. 11, 2653-2665
24. Zhang, H., Li, X. J., Martin, D. B., and Aebersold, R. (2003) Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry. Nat. Biotechnol. 21, 660-666 (Pubitemid 36638093)
25. Zhang, H., Yi, E. C., Li, X.-j., Mallick, P., Kelly-Spratt, K. S., Masselon, C. D., Camp, D. G., Smith, R. D., Kemp, C. J., and Aebersold, R. (2005) High throughput quantitative analysis of serum proteins using glycopeptide capture and liquid chromatography mass spectrometry. Mol. Cell. Proteomics 4, 144-155 (Pubitemid 40361177)
26. Zhang, H., Liu, A. Y., Loriaux, P., Wollscheid, B., Zhou, Y., Watts, J. D., and Aebersold, R. (2007) Mass spectrometric detection of tissue proteins in plasma. Mol. Cell. Proteomics 6, 64-71 (Pubitemid 46152692)
27. Hirabayashi, J., and Kasai, K.-i. (2002) Separation technologies for glycomics. J. Chromatography B Analyt. Technol. Biomed. Life Sci., 771, 67-87 (Pubitemid 34457722)
28. Bunkenborg, J., Pilch, B. J., Podtelejnikov, A. V., and Wisniewski, J. R. (2004) Screening for N-glycosylated proteins by liquid chromatography mass spectrometry. Proteomics 4, 454-465 (Pubitemid 38235265)
29. Zielinska, D. F., Gnad, F., Wiśniewski, J. R., and Mann, M. (2010) Precision mapping of an in vivo N-glycoproteome reveals rigid topological and sequence constraints. Cell 141, 897-907
30. Zielinska, D. F., Gnad, F., Schropp, K., Wiśniewski, J. R., and Mann, M. (2012) Mapping N-glycosylation sites across seven evolutionarily distant species reveals a divergent substrate proteome despite a common core machinery. Mol. Cell 46, 542-548
31. Geiger, T., Cox, J., Ostasiewicz, P., Wisniewski, J. R., and Mann, M. (2010) Super-SILAC mix for quantitative proteomics of human tumor tissue. Nat. Methods 7, 383-385
32. Rappsilber, J., Mann, M., and Ishihama, Y. (2007) Protocol for micropurification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips. Nat. Protocols 2, 1896-1906 (Pubitemid 47308128)
33. Michalski, A., Damoc, E., Lange, O., Denisov, E., Nolting, D., Mueller, M., Viner, R., Schwartz, J., Remes, P., Belford, M., Dunyach, J.-J., Cox, J., Horning, S., Mann, M., and Makarov, A. (2011) Ultra high resolution linear ion trap Orbitrap mass spectrometer (Orbitrap Elite) facilitates top down LC MS/MS and versatile peptide fragmentation modes. Mol. Cell. Proteomics 11, mcp.O111.013698
34. Michalski, A., Damoc, E., Hauschild, J.-P., Lange, O., Wieghaus, A., Makarov, A., Nagaraj, N., Cox, J., Mann, M., and Horning, S. (2011) Mass spectrom-etry- based proteomics using Q Exactive, a high-performance benchtop quadrupole Orbitrap mass spectrometer. Mol. Cell. Proteomics 10, mcp.M111.011015
35. Cox, J., and Mann, M. (2008) MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367-1372
36. Cox, J., Neuhauser, N., Michalski, A., Scheltema, R. A., Olsen, J. V., and Mann, M. (2011) Andromeda: A peptide search engine integrated into the MaxQuant environment. J. Proteome Res. 10, 1794-1805
37. Palmisano, G., Melo-Braga, M. N., Engholm-Keller, K., Parker, B. L., and Larsen, M. R. (2012) Chemical deamidation: A common pitfall in large-scale N-linked glycoproteomic mass spectrometry-based analyses. J. Proteome Res. 11, 1949-1957
38. Geiger, T., Wisniewski, J. R., Cox, J., Zanivan, S., Kruger, M., Ishihama, Y., and Mann, M. (2011) Use of stable isotope labeling by amino acids in cell culture as a spike-in standard in quantitative proteomics. Nat. Protocols 6, 147-157
39. Gonzalez, J., Takao, T., Hori, H., Besada, V., Rodriguez, R., Padron, G., and Shimonishi, Y. (1992) A method for determination of N-glycosylation sites in glycoproteins by collision-induced dissociation analysis in fast atom bombardment mass spectrometry: Identification of the positions of carbohydrate- linked asparagine in recombinant α-amylase by treatment with peptide-N-glycosidase F in 18O-labeled water. Anal. Biochem. 205, 151-158
40. Küster, B., and Mann, M. (1999) O-18-labeling of N-glycosylation sites to improve the identification of gel-separated glycoproteins using peptide mass mapping and database searching. Anal. Chem. 71, 1431-1440 (Pubitemid 29177305)
41. Yen, T. Y., Macher, B. A., McDonald, C. A., Alleyne-Chin, C., and Timpe, L. C. (2011) Glycoprotein profiles of human breast cells demonstrate a clear clustering of normal/benign versus malignant cell lines and basal versus luminal cell lines. J. Proteome Res. 11, 656-667
42. Drake, P. M., Schilling, B., Niles, R. K., Prakobphol, A., Li, B., Jung, K., Cho, W., Braten, M., Inerowicz, H. D., Williams, K., Albertolle, M., Held, J. M., Iacovides, D., Sorensen, D. J., Griffith, O. L., Johansen, E., Zawadzka, A. M., Cusack, M. P., Allen, S., Gormley, M., Hall, S. C., Witkowska, H. E., Gray, J. W., Regnier, F., Gibson, B. W., and Fisher, S. J. (2012) Lectin chromatography/mass spectrometry discovery workflow identifies putative biomarkers of aggressive breast cancers. J. Proteome Res.
43. Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A. P., Dolinski, K., Dwight, S. S., Eppig, J. T., Harris, M. A., Hill, D. P., Issel-Tarver, L., Kasarskis, A., Lewis, S., Matese, J. C., Richardson, J. E., Ringwald, M., Rubin, G. M., and Sherlock, G. (2000) Gene ontology: tool for the unification of biology. Nat. Genet. 25, 25-29 (Pubitemid 30257031)
44. Petersen, T. N., Brunak, S., von Heijne, G., and Nielsen, H. (2011) SignalP 4.0: discriminating signal peptides from transmembrane regions. Nat. Meth. 8, 785-786
45. Bendtsen, J. D., Kiemer, L., Fausboll, A., and Brunak, S. (2005) Nonclassical protein secretion in bacteria. BMC Microbiology 5, 58
46. Turner, N., Pearson, A., Sharpe, R., Lambros, M., Geyer, F., Lopez-Garcia, M. A., Natrajan, R., Marchio, C., Iorns, E., Mackay, A., Gillett, C., Grigoriadis, A., Tutt, A., Reis-Filho, J. S., and Ashworth, A. (2010) FGFR1 Amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer. Cancer Res. 70, 2085-2094
47. Qiu, L., Zhou, C., Sun, Y., Di, W., Scheffler, E., Healey, S., Kouttab, N., Chu, W., and Wan, Y. (2006) Crosstalk between EGFR and TrkB enhances ovarian cancer cell migration and proliferation. Int. J. Oncol. 29, 1003-1011
48. Zhang, S., Chen, L., Cui, B., Chuang, H. Y., Yu, J., Wang-Rodriguez, J., Tang, L., Chen, G., Basak, G. W., and Kipps, T. J. (2012) ROR1 is expressed in human breast cancer and associated with enhanced tumorcell growth. PLoS ONE 7, e31127
49. Uhland, K. (2006) Matriptase and its putative role in cancer. Cell. Mol. Life Sci. 63, 2968-2978
50. Lue, H. W., Yang, X., Wang, R., Qian, W., Xu, R. Z. H., Lyles, R., Osunkoya, A. O., Zhou, B. P., Vessella, R. L., Zayzafoon, M., Liu, Z. R., Zhau, H. E., and Chung, L. W. (2011) LIV-1 promotes prostate cancer epithelial-tomesenchymal transition and metastasis through HB-EGF shedding and EGFR-mediated ERK signaling. PLoS ONE 6, e27720
51. Thiery, J. P., Acloque, H., Huang, R. Y., and Nieto, M. A. (2009) Epithelialmesenchymal transitions in development and disease. Cell 139, 871-890
52. Koli, K., Saharinen, J., Hyytiäinen, M., Penttinen, C., and Keski-Oja, J. (2001) Latency, activation, and binding proteins of TGF-β. Microscopy Res. Tech. 52, 354-362 (Pubitemid 32167823)
53. Koli, K., and Keski-Oja, J. (1995) 1,25-Dihydroxyvitamin D3 enhances the expression of transforming growth factor β1 and its latent form binding protein in cultured breast carcinoma cells. Cancer Res. 55, 1540-1546
54. Zijlstra, A. (2010) Tetraspanins in Cancer Cell-Extracellular Matrix Interactions in Cancer. In: Zent, R., and Pozzi, A., eds., pp. 217-243, Springer New York
55. Neufeld, G., and Kessler, O. (2008) The semaphorins: versatile regulators of tumour progression and tumour angiogenesis. Nat. Rev. Cancer 8, 632-645
56. Parikh, A. A., Fan, F., Liu, W. B., Ahmad, S. A., Stoeltzing, O., Reinmuth, N., Bielenberg, D., Bucana, C. D., Klagsbrun, M., and Ellis, L. M. (2004) Neuropilin-1 in human colon cancer: expression, regulation, and role in induction of angiogenesis. Am. J. Pathol. 164, 2139-2151 (Pubitemid 38669361)
57. Swiercz, J. M., Worzfeld, T., and Offermanns, S. (2008) ErbB-2 and Met reciprocally regulate cellular signaling via plexin-B1. J. Biol. Chem. 283, 1893-1901
58. Haagensen, D. E., Silva, J. S., Leight, G. S., Dilley, W. G., and Wells, S. A. (1981) fluoxymesterone stimulates plasma-concentrations of gross cystic- disease fluid protein in patients with metastatic breast-carcinoma. Surg. Forum 32, 413-414 (Pubitemid 12159580)
59. Cassoni, P., Sapino, A., Haagensen, D. E., Naldoni, C., and Bussolati, G. (1995) mitogenic effect of the 15-kda gross cystic-disease fluid protein (gcdfp-15) on breast-cancer cell-lines and on immortal mammary cells. Int. J. Cancer 60, 216-220
60. Dennis, J. L., Hvidsten, T. R., Wit, E. C., Komorowski, J., Bell, A. K., Downie, I., Mooney, J., Verbeke, C., Bellamy, C., Keith, W. N., and Oien, K. A. (2005) Markers of adenocarcinoma characteristic of the site of origin: development of a diagnostic algorithm. Clin. Cancer Res. 11, 3766-3772 (Pubitemid 40685594)
61. Sapino, A., Righi, L., Cassoni, P., Papotti, M., Gugliotta, P., and Bussolati, G. (2001) Expression of apocrine differentiation markers in neuroendocrine breast carcinomas of aged women. Mod. Pathol. 14, 768-776 (Pubitemid 33069835)
62. Hahnel, R., and Hahnel, E. (1996) Expression of the PIP/GCDFP-15 gene and survival in breast cancer. Virchows Arch. Int. J. Pathol. 429, 365-369 (Pubitemid 26421397)
63. Hassan, M. I., Bilgrami, S., Kumar, V., Singh, N., Yadav, S., Kaur, P., and Singh, T. P. (2008) Crystal structure of the novel complex formed between zinc α2-glycoprotein (ZAG) and prolactin-inducible protein (PIP) from human seminal plasma. J. Mol. Biol. 384, 663-672
64. Díez-Itza, I., Sánchez, L. M., Teresa Allende, M., Vizoso, F., Ruibal, A., and López-Otín, C. (1993) Zn-α2-glycoprotein levels in breast cancer cytosols and correlation with clinical, histological and biochemical parameters. Eur. J. Cancer 29, 1256-1260
65. Yang, T., Zhang, J. S., Massa, S. M., Han, X., and Longo, F. M. (1999) Leukocyte common antigen-related tyrosine phosphatase receptor: Increased expression and neuronal-type splicing in breast cancer cells and tissue. Mol. Carcinogenesis 25, 139-149 (Pubitemid 29275027)
66. Oskarsson, T., Acharyya, S., Zhang, X. H., Vanharanta, S., Tavazoie, S. F., Morris, P. G., Downey, R. J., Manova-Todorova, K., Brogi, E., and Massague, J. (2011) Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs. Nat. Med. 17, 867-874
67. Uhlen, M., Oksvold, P., Fagerberg, L., Lundberg, E., Jonasson, K., Forsberg, M., Zwahlen, M., Kampf, C., Wester, K., Hober, S., Wernerus, H., Bjorling, L., and Ponten, F. (2010) Towards a knowledge-based Human Protein Atlas. Nat. Biotech. 28, 1248-1250
68. Yadav, A. K., Bhardwaj, G., Basak, T., Kumar, D., Ahmad, S., Priyadarshini, R., Singh, A. K., Dash, D., and Sengupta, S. (2011) A systematic analysis of eluted fraction of plasma post immunoaffinity depletion: implications in biomarker discovery. PLoS ONE 6, e24442
69. Monetti, M., Nagaraj, N., Sharma, K., and Mann, M. (2011) Large-scale phosphosite quantification in tissues by a spike-in SILAC method. Nat. Meth. 8, 655-658
70. Picotti, P., and Aebersold, R. (2012) Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions. Nat. Meth. 9, 555-566
71. Gallien, S., Duriez, E., and Domon, B. (2011) Selected reaction monitoring applied to proteomics. J. Mass Spectrom. 46, 298-312